Michelle Tutt

Michelle Tutt is an experienced professional in project management and early development asset operations within the pharmaceutical industry. Holding senior roles at Ipsen from May 2024 to March 2025, including Head of Early Development Asset Operations, and previously serving as Senior Program Manager at Reneo Pharmaceuticals from September 2018 to May 2024, Michelle has successfully partnered with global functional leads to develop high-quality project plans and facilitate multidisciplinary team meetings. Prior experience at Pfizer from October 2004 to August 2011 involved leadership as Senior Principal Scientist in Pain and Anti-viral research units, overseeing resource management and project portfolios while promoting operational excellence through Lean Six Sigma and Agile methodologies. Educational qualifications include a BSc in Physiology from the University of St Andrews, earned from September 1993 to June 1997.